Tags

Type your tag names separated by a space and hit enter

Update on calciphylaxis etiopathogenesis, diagnosis, and management.
Cutis 2018; 102(6):395-400C

Abstract

Calciphylaxis is a rare painful skin condition classically seen in patients with end-stage renal disease (ESRD), particularly those on chronic dialysis; however, it also has been increasingly reported in patients with normal renal function. Calciphylaxis is associated with high mortality rates, and excruciating pain and nonhealing ulcers often lead to recurrent hospitalizations and infectious complications. It is critical for dermatologists to recognize the clinical features of calciphylaxis to ensure accurate and timely diagnosis and proper management. In this article, we provide an update on calciphylaxis etiopathogenesis, diagnosis, and management, and we highlight the challenges faced in managing this potentially fatal condition.

Authors+Show Affiliations

Department of Dermatology, Cleveland Clinic, Ohio, USA.Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, USA.Department of Dermatology, Oregon Health and Science University, Portland, USA.Department of Dermatology, Massachusetts General Hospital, Boston, USA.Department of Dermatology, Oregon Health and Science University, Portland, USA.Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.Departments of Dermatology and Medicine, University of Pennsylvania, Philadelphia, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30657805

Citation

Khanna, Urmi, et al. "Update On Calciphylaxis Etiopathogenesis, Diagnosis, and Management." Cutis, vol. 102, no. 6, 2018, pp. 395-400.
Khanna U, Dominguez A, Keller J, et al. Update on calciphylaxis etiopathogenesis, diagnosis, and management. Cutis. 2018;102(6):395-400.
Khanna, U., Dominguez, A., Keller, J., Kroshinsky, D., Ortega-Loayza, A. G., Strowd, L., & Micheletti, R. G. (2018). Update on calciphylaxis etiopathogenesis, diagnosis, and management. Cutis, 102(6), pp. 395-400.
Khanna U, et al. Update On Calciphylaxis Etiopathogenesis, Diagnosis, and Management. Cutis. 2018;102(6):395-400. PubMed PMID: 30657805.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update on calciphylaxis etiopathogenesis, diagnosis, and management. AU - Khanna,Urmi, AU - Dominguez,Arturo, AU - Keller,Jesse, AU - Kroshinsky,Daniela, AU - Ortega-Loayza,Alex G, AU - Strowd,Lindsay, AU - Micheletti,Robert G, PY - 2019/1/19/entrez PY - 2019/1/19/pubmed PY - 2019/4/26/medline SP - 395 EP - 400 JF - Cutis JO - Cutis VL - 102 IS - 6 N2 - Calciphylaxis is a rare painful skin condition classically seen in patients with end-stage renal disease (ESRD), particularly those on chronic dialysis; however, it also has been increasingly reported in patients with normal renal function. Calciphylaxis is associated with high mortality rates, and excruciating pain and nonhealing ulcers often lead to recurrent hospitalizations and infectious complications. It is critical for dermatologists to recognize the clinical features of calciphylaxis to ensure accurate and timely diagnosis and proper management. In this article, we provide an update on calciphylaxis etiopathogenesis, diagnosis, and management, and we highlight the challenges faced in managing this potentially fatal condition. SN - 2326-6929 UR - https://www.unboundmedicine.com/medline/citation/30657805/Update_on_calciphylaxis_etiopathogenesis_diagnosis_and_management_ L2 - https://www.mdedge.com/dermatology/article/189412/wounds/update-calciphylaxis-etiopathogenesis-diagnosis-and-management DB - PRIME DP - Unbound Medicine ER -